 |
|
Study shows suppressing herpes virus may reduce infectiousness of HIV
November 16, 2007A recent study of men co-infected with herpes simplex virus type 2 (HSV-2) and HIV revealed that drugs used to suppress HSV decrease the levels of HIV in the blood and rectal secretions, which may make patients less likely to transmit the virus. This study is published in the November 15 issue of the Journal of Infectious Diseases, now available online.
Most HIV-infected persons are also infected with HSV-2, which is the major cause of genital herpes. Prior studies demonstrated that the risk of passing HIV to a sexual partner is greater when the HIV-infected person has genital ulcers caused by HSV. Previous studies among HIV/HSV-2 co-infected persons and test-tube research have also demonstrated that HIV levels are increased during genital HSV reactivation.
In a pilot study of the effect of HSV-2 suppression on levels of HIV infectiousness, Connie Celum, MD, MPH, Richard Zuckerman, MD, MPH, and a team of researchers at the University of Washington and the research organization Impacta, in Lima, Peru performed a randomized, placebo-controlled cross-over study of daily HSV suppressive treatment in a small group of HIV/HSV-2 co-infected men who have sex with men.
Twenty men aged 22 to 41 enrolled in this trial, which took place in Peru. The men studied had no prior antiretroviral therapy and were not currently receiving antiretroviral therapy for HIV infection. Subjects were randomly assigned to the anti-HSV drug, valacyclovir 500 mg, twice daily or matching placebo for initial treatment. After eight weeks, subjects had a "washout period" in which they received twice daily placebo. Subjects then crossed over to the alternative treatment (placebo or valacyclovir) for eight weeks. Participants visited the clinic three times a week during each treatment arm. At each visit, rectal secretions were collected and weekly blood samples were obtained to determine levels of HIV.
Dr. Celum and her team of researchers found significantly reduced levels of HIV in blood by about 50 percent and rectal secretions by about 30 percent during the 8 weeks when the HIV/HSV-2 co-infected men received valacyclovir to suppress reactivation of HSV. This reduction in HIV levels could have a significant impact on transmission of HIV. Since the only intervention was daily valacyclovir to suppress HSV, this study adds weight to the other evidence that HSV-2 reactivation increases HIV replication. According to the researchers, additional "ongoing randomized trials will answer whether HSV suppression can reduce HIV transmission and address the potential for HSV suppression to delay anti-HIV therapy (antiretroviral) initiation."
Infectious Diseases Society of America
Twenty men aged 22 to 41 enrolled in this trial, which took place in Peru. The men studied had no prior antiretroviral therapy and were not currently receiving antiretroviral therapy for HIV infection. Subjects were randomly assigned to the anti-HSV drug, valacyclovir 500 mg, twice daily or matching placebo for initial treatment. After eight weeks, subjects had a "washout period" in which they received twice daily placebo. Subjects then crossed over to the alternative treatment (placebo or valacyclovir) for eight weeks. Participants visited the clinic three times a week during each treatment arm. At each visit, rectal secretions were collected and weekly blood samples were obtained to determine levels of HIV.
Dr. Celum and her team of researchers found significantly reduced levels of HIV in blood by about 50 percent and rectal secretions by about 30 percent during the 8 weeks when the HIV/HSV-2 co-infected men received valacyclovir to suppress reactivation of HSV. This reduction in HIV levels could have a significant impact on transmission of HIV. Since the only intervention was daily valacyclovir to suppress HSV, this study adds weight to the other evidence that HSV-2 reactivation increases HIV replication. According to the researchers, additional "ongoing randomized trials will answer whether HSV suppression can reduce HIV transmission and address the potential for HSV suppression to delay anti-HIV therapy (antiretroviral) initiation."
Infectious Diseases Society of America
Science News and Science Current Events Tag Cloud
This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size.
Nausea Kidney Stones Elephants Hurricanes HIV treatment Neuroticism Cisplatin Nanotube Snowmelt Nanotechnology Vaccination Lymphoma Macular Degeneration Drug-eluting Stents Gold Nanoparticles Infants Dengue Virus Amphibians Colon Cancer Data Storage Cell Membrane Thyroid Colonoscopy Clostridium difficile Organic Matter
See More: Science News Tags
Herpes Virus Current Events and Herpes Virus News RSSResearchers testing virus-gene therapy combination against melanoma
Researchers at the Moores UCSD Cancer Center are injecting a modified herpes virus into melanoma tumors, hoping to kill the cancer cells while also bolstering the body's immune defenses against the disease.
Study indicates that a common virus could cause high blood pressure
A new study suggests for the first time that cytomegalovirus (CMV), a common viral infection affecting between 60 and 99 percent of adults worldwide, is a cause of high blood pressure, a leading risk factor for heart disease, stroke and kidney disease.
Herpes medication does not reduce risk of HIV transmission
A recently completed international multi-center clinical trial has found that acyclovir, a drug widely used as a safe and effective treatment to suppress herpes simplex virus-2 (HSV-2), which is the most common cause of genital herpes, does not reduce the risk of HIV transmission when taken by people infected with both HIV and HSV-2.
Potential new herpes therapy studied
A new therapy being developed at the University of Florida could, in time, produce another weapon for the fight against herpes.
Engineered virus targets and kills apparent cancer stem cells in neuroblastoma
After identifying an apparent population of cancer stem cells for neuroblastoma, researchers successfully used a reprogrammed herpes virus to block tumor formation in mice by targeting and killing the cells.
OHSU finds association between Epstein-Barr virus, inflammatory diseases of the mouth
Researchers at Oregon Health & Science University's School of Dentistry (www.ohsu.edu/sod) have found that a significant percentage of dental patients with the inflammatory diseases irreversible pulpitis and apical periodontitis also have the Epstein-Barr virus.
Keeping herpes infection in check: Pitt researchers describe immune system strategies
Herpes simplex virus type I can cause bouts of cold sores, blindness and potentially lethal encephalitis when it reawakens from a quiescent state in the nerve cells it infects.
U of T researchers reveal Epstein-Barr virus protein contributes to cancer
Researchers at the University of Toronto have discovered that the EBNA1 protein of Epstein-Barr virus (EBV) disrupts structures in the nucleus of nasopharyngeal carcinoma (NPC) cells, thereby interfering with cellular processes that normally prevent cancer development.
Deadly rugby virus spreads in sumo wrestlers
Rugby players may get more than just the ball out of a scrum - herpes virus can cause a skin disease called "scrumpox" and it spreads through physical contact.
Herpes drug inhibits HIV in patients infected with both viruses
Researchers at the U.S. National Institutes of Health (NIH), McGill University and other institutions have discovered how a simple antiviral drug developed decades ago suppresses HIV in patients who are also infected with herpes.
More Herpes Virus Current Events and Herpes Virus News Articles
|
Peak Immunity: How to Fight Epstein-Barr Virus, Candida, Herpes Simplex Viruses and Other Immuno-Depressive Conditions and Win by Luc De Schepper (Author) | |
|
Herpes Simplex Virus Protocols (Methods in Molecular Medicine) by Humana Press Univ. of Glasglow, Scotland. Text offering up-to-date practical information useful to new workers in the field. For virologists, microbiologists, and infectious disease investigators. Modified-outline format. Halftone illustrations and graphs. DNLM: Herpes Simplex--diagnosis. | |
 |
HERPES (HERPES SIMPLEX VIRUS 2) GIANT MICROBES by Giant Microbes GIANTmicrobes are fun and educational?a great way to learn about various health topics and the microscopic critters that are found in and around us. Each microbe character is 5-7? in size--over a million times their actual size! Perfect for teachers, parents and budding scientists?they also make humorous gifts. Each microbe comes with an information tag including scientific name, an image of the actual microbe, and a mini history and science lesson. Not suitable for children under 3 years. Our products are made by top manufacturers who care about toy safety, quality and value. Your order will ship factory fresh directly from our warehouse to your door. We carefully inspect and beautifully package every order before shipment to ensure that you receive high quality products that are... |
 |
Herpes Treatment - H Prevention Herpes and Cold Sore, Simplex 1 and 2 Virus Outbreak Prevention 11ml by Healing Natural Oils Essential oils are the natural way to achieve health, well-being, vitality and low stress levels. Many of those who carry the herpes virus find this to be a very stressful situation. They worry about when the next outbreak will occur and they worry about passing on the virus to others. Our H-Prevention, which is specially formulated from essentials oils, will help to eliminate a lot of this stress by controlling recurring outbreaks. H-Prevention is 100% natural and organic at source. No pesticides, herbicides or chemical fertilizers have been used during the growth of the plants from which the oils are extracted. H-Prevention provides an effective daily maintenance herpes preventative program to control outbreaks. The herpes virus resides at the top and the base of your spine and... |
 |
Herpes Simplex Virus Epithelial Keratitis: In Vivo Morphology in the Human Cornea by Helena M. Tabery (Author) This book on Herpes Simplex Virus Epithelial Keratitis shows a kind of ‘living histology’, revealing both morphological and dynamic features of the disease, and explaining mechanisms behind them. It offers great insights helpful for the differential diagnostics and the recognition of less known variants as well as of complications. It is also highly useful for the follow–up of treatment results and the differentiation between an active infection and sequelae. Thus, this book will be an invaluable aid for ophthalmologists and researchers working with ocular surface diseases. |
 |
Peaceful Mountain Cold Sore Rescue, .27-Ounce Packages (Pack of 3) by Klearsen All natural cold sore and fever blister relief. Combining herbal formulas with modern science. Uniquely formulated to soothe sores. Advance herbal formula for cold sores and fever blisters. Supports tissue repair. Protects open sores with aloe vera. Natur |
 |
Viralys POWDER 100 gm 3 Pack by Vetoquinol Viralys Powder is a L-lysine supplement in a palatable flavor powder for cats. Viralys is recommended as an aid in the treatment of Feline Herpes Virus and its associated respiratory and ocular symptoms. |
 |
Herpes Simplex Viruses by Informa HealthCare This reference studies the epidemiology, identification, pathogenesis, and clinical features of diseases associated with herpes simplex viruses including herpes labialis, ocular herpes, herpes genitalis, cutaneous herpes, meningitis, encephalitis, and neonatal herpes-evaluating the latest treatment regimens, mechanisms of immune response and evasion, and research related to vaccines for the prevention and reduction of HSV outbreaks. |
 |
BIRD FLU 2 oz Tincture/Extract by ALTERNATIVE Health & Herbs REMEDIES "High" risk of more easily spread bird flu formWHO - GENEVA (Reuters) July 6th 2006The risk of bird flu mutating into a form more easily spread between people is still high and there could be an upswing in human infections at the end of the year, the World Health Organisation (WHO) warned in June 2006. In a report analysing more than 200 known bird flu cases, the United Nations agency identified three peaks in human infections since 2003, all concentrated during the winter and spring seasons in the northern hemisphere. "If this pattern continues, an upsurge in cases could be anticipated starting in late 2006 or early 2007," the WHO said, adding that further analysis was needed. The WHO study of human cases of H5N1 between December 2003 and April 2006during which 203 people caught the... |
 |
Herpes Simplex Virus Protocols (Methods in Molecular Medicine) by S. Moira Brown (Editor), Alasdair R. MacLean (Editor) Univ. of Glasglow, Scotland. Text offering up-to-date practical information useful to new workers in the field. For virologists, microbiologists, and infectious disease investigators. Modified-outline format. Halftone illustrations and graphs. DNLM: Herpes Simplex--diagnosis. |
| © 2009 BrightSurf.com |